BioSpace News Archive

For the First Time, Images Show Rapid Spread of Infection May be Explained by Extensive Filopodia, Stringy Protrusions in Virally Infected Cells

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

Shenzhen Hepalink Pharmaceutical Group Co., Ltd., a China-based global pharmaceutical company targeting high-mortality diseases with significant unmet medical needs, announced exciting regulatory milestones in both the marketed pharmaceutical business and its pipeline development.

Chinese insulin manufacturer Gan & Lee Pharmaceuticals, Qiming’s portfolio company lands on the A-shares main board market. The issue price of Gan & Lee is RMB 63.32 per share.

Celltrion Healthcare announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended expanding the existing marketing authorisation for the subcutaneous formulation of Remsima® in an additional five indications: for the treatment of patients with ankylosing spondylitis, Crohn’s disease, ulcerative colitis, psoriatic arthritis and psoriasis.

On June 29, 2020, Burning Rock Biotech Limited announced a strategic partnership with CStone Pharmaceuticals to co-develop and commercialize companion diagnostics for pralsetinib, an investigational treatment developed by CStone’s partner Blueprint Medicines, in China for the detection of RET alterations in cancer patients.